메뉴 건너뛰기
Medecine/Sciences
Volumn 25, Issue 12, 2009, Pages 1113-1115
Monoclonal antibodies in multiple sclerosis;Anticorps monoclonaux dans la sclérose en plaques
Author keywords

[No Author keywords available]
Indexed keywords

EID: 74749085980     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200925121113     Document Type: Review
Times cited : (3)
References (5)
  • 1
    • 33644584352 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of Natalizumab for relapsing multiple sclerosis
    • Polmon CH, O'Connor P, Havrdova E, et al. A randomized, placebo-controlled trial of Natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 ; 354 : 899-910.
    • (2006) N Engl J Med , vol.354 , pp. 899-910
    • Polmon, C.H.1    O'Connor, P.2    Havrdova, E.3
  • 2
    • 33644605483 scopus 로고    scopus 로고
    • Evaluation for progressive multifocal leuko-encephalopathy in patients treated with natalizumab
    • Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation for progressive multifocal leuko-encephalopathy in patients treated with natalizumab. N Engl J Med 2006 ; 355 : 924-33.
    • (2006) N Engl J Med , vol.355 , pp. 924-933
    • Yousry, T.A.1    Major, E.O.2    Ryschkewitsch, C.3
  • 3
    • 70350061593 scopus 로고    scopus 로고
    • Balancing risk and reward: The question of natalizumab
    • Hauser SL, Johnston SC. Balancing risk and reward: the question of natalizumab. Ann Neurol 2009 ; 66 : A7-8.
    • (2009) Ann Neurol , vol.66
    • Hauser, S.L.1    Johnston, S.C.2
  • 4
    • 54949143968 scopus 로고    scopus 로고
    • Alemtuzumab vs. interferon beta-1α in early multiple sclerosis. CAMMS223 trial investigators
    • Coles AJ, Compston DA, Compston DA, et al. Alemtuzumab vs. interferon beta-1α in early multiple sclerosis. CAMMS223 trial investigators. N Engl J Med 2008 ; 359 : 1786-801.
    • (2008) N Engl J Med , vol.359 , pp. 1786-1801
    • Coles, A.J.1    Compston, D.A.2    Compston, D.A.3
  • 5
    • 70449418132 scopus 로고    scopus 로고
    • Rituximanb in patients with primary progressive multiple sclerosis: Results of a randomized double blind placebo-controlled multicenter trial
    • Hawker K, O'Connor P, Freedman MS, et al. Rituximanb in patients with primary progressive multiple sclerosis: results of a randomized double blind placebo-controlled multicenter trial. Ann Neurol 2009 ; 66 : 460-71.
    • (2009) Ann Neurol , vol.66 , pp. 460-471
    • Hawker, K.1    O'Connor, P.2    Freedman, M.S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.